Sk Pharma

Sk Pharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

βœͺ π—¦π—ž 𝗣𝗛𝗔π—₯𝗠𝗔 is a pioneering global pharmaceutical company. SK-Pharma provides and launches value-added medicines, complex generics, and patient-centric healthcare solutions. Our mission is to enhance well-being by ensuring essential medicines are accessible to all patients, particularly those in need. βœͺ Commitment to Innovation & Personalization Striving to create a healthcare environment where accessibility, personalization, and innovation meet, thereby significantly improving patient outcomes and enhancing quality of life. βœͺ π—¦π—ž 𝗣𝗛𝗔π—₯𝗠𝗔 is one stop solution for introduction of new therapeutics to answer unmet needs. Our company follows through with all demands regarding new products introduction, from registration through marketing and promotion, to distribution. βœͺ π—¦π—ž 𝗣𝗛𝗔π—₯𝗠𝗔 dynamic team is constantly monitoring new marketing technologies to enhance stakeholders value. We have a strong lobbying department for introduction of new pharmaceutical products, and are consistently selected as recipients of governmental tenders. Our international, multilingual, experienced staff is rigorously scouting for new technologies to improve patients’ life, with patient centric approach philosophy, understanding the patient journey and answering he’s immediate unmet needs. βœͺ Our reputation is highly important to us and we take pride in absolute, unrelenting follow-through with commitments.

Company Details

Employees
78
Founded
-
Address
94 Yigal Alon St., Alon Tower 2,38th Floor,israel
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Tel Aviv, Tel Aviv
Looking for a particular Sk Pharma employee's phone or email?

Sk Pharma Questions

News

SK pharmteco Opens New cGMP Plasmid Suite in King of Prussia - Contract Pharma

SK pharmteco Opens New cGMP Plasmid Suite in King of Prussia Contract Pharma

SK Life Science starts TV ad campaign to drive patients to seizure drug Xcopri - Fierce Pharma

SK Life Science starts TV ad campaign to drive patients to seizure drug Xcopri Fierce Pharma

Pfizer loses pneumococcal vaccine patent case against SK bio - FirstWord Pharma

Pfizer loses pneumococcal vaccine patent case against SK bio FirstWord Pharma

SK pharmteco Opens New CGMP Plasmid Suite in King of Prussia - Contract Pharma

SK pharmteco Opens New CGMP Plasmid Suite in King of Prussia Contract Pharma

SK defeats Pfizer in Korean patent feud, opening new lines of business for pneumococcal vaccine - Fierce Pharma

SK defeats Pfizer in Korean patent feud, opening new lines of business for pneumococcal vaccine Fierce Pharma

Adalvo Partners With SK Pharma to Create Arphio, a New Business Entity Dedicated Solely to Orphan and Rare Disease Medicines - Business Wire

Adalvo Partners With SK Pharma to Create Arphio, a New Business Entity Dedicated Solely to Orphan and Rare Disease Medicines Business Wire

SK Biopharm taps Full-Life for first foray into radiopharmaceuticals - FirstWord Pharma

SK Biopharm taps Full-Life for first foray into radiopharmaceuticals FirstWord Pharma

SK pharmteco Unifies Brands to Create CDMO Powerhouse - Contract Pharma

SK pharmteco Unifies Brands to Create CDMO Powerhouse Contract Pharma

After holding out, bluebird bio investors get on board with sale to Carlyle, SK Capital - Fierce Pharma

After holding out, bluebird bio investors get on board with sale to Carlyle, SK Capital Fierce Pharma

Bluebird, after exploring 2nd buyout offer, sticks with Carlyle and SK Capital deal - Fierce Pharma

Bluebird, after exploring 2nd buyout offer, sticks with Carlyle and SK Capital deal Fierce Pharma

SK pharmteco Acquires Controlling Interest in CBM - Contract Pharma

SK pharmteco Acquires Controlling Interest in CBM Contract Pharma

Once valued at $10B, bluebird bio sold to private equity firms for $29M - Fierce Pharma

Once valued at $10B, bluebird bio sold to private equity firms for $29M Fierce Pharma

Bluebird bio investor reluctance pays off as Carlyle, SK improve buyout offer by 67% - Fierce Pharma

Bluebird bio investor reluctance pays off as Carlyle, SK improve buyout offer by 67% Fierce Pharma

Full-Life Technologies, SK Biopharma Enter $571.5M License Agreement for FL-091 - Contract Pharma

Full-Life Technologies, SK Biopharma Enter $571.5M License Agreement for FL-091 Contract Pharma

Bluebird bio receives rival M&A bid worth 50% higher than Carlyle-SK offer - Fierce Pharma

Bluebird bio receives rival M&A bid worth 50% higher than Carlyle-SK offer Fierce Pharma

SK Biopharmaceuticals Adopts Veeva Vault Validation Management - Contract Pharma

SK Biopharmaceuticals Adopts Veeva Vault Validation Management Contract Pharma

CDMOs SK pharmteco, Oxford Biomedica make cell and gene therapy manufacturing M&A plays - Fierce Pharma

CDMOs SK pharmteco, Oxford Biomedica make cell and gene therapy manufacturing M&A plays Fierce Pharma

Fierce Pharma Asiaβ€”BMS' China asset sale; 2 biotech debuts; 2 potential deals - Fierce Pharma

Fierce Pharma Asiaβ€”BMS' China asset sale; 2 biotech debuts; 2 potential deals Fierce Pharma

SK plots next phase of growth with plans for $261M 'vaccine ecosystem' in Korea - Fierce Pharma

SK plots next phase of growth with plans for $261M 'vaccine ecosystem' in Korea Fierce Pharma

SK pharmteco to build $260M small molecule and peptide production facility in South Korea - Fierce Pharma

SK pharmteco to build $260M small molecule and peptide production facility in South Korea Fierce Pharma

SK Bioscience begins 'globalization' push, paying $244M for majority stake in contract manufacturer IDT Biologika - Fierce Pharma

SK Bioscience begins 'globalization' push, paying $244M for majority stake in contract manufacturer IDT Biologika Fierce Pharma

Ferring and SK Pharmteco Partner to Increase Production of ADSTILADRIN - Contract Pharma

Ferring and SK Pharmteco Partner to Increase Production of ADSTILADRIN Contract Pharma

SK Capital buys generics producer Apotex, troubled since the murder of founder Barry Sherman - Fierce Pharma

SK Capital buys generics producer Apotex, troubled since the murder of founder Barry Sherman Fierce Pharma

Ferring taps CDMO SK pharmteco to boost long-term supply of gene therapy Adstiladrin - Fierce Pharma

Ferring taps CDMO SK pharmteco to boost long-term supply of gene therapy Adstiladrin Fierce Pharma

With $900M IPO, SK Bioscience has big plans for manufacturing expansionβ€”even beyond COVID-19 vaccines - Fierce Pharma

With $900M IPO, SK Bioscience has big plans for manufacturing expansionβ€”even beyond COVID-19 vaccines Fierce Pharma

Highlights from the DCAT Member Company Announcement Forum - Contract Pharma

Highlights from the DCAT Member Company Announcement Forum Contract Pharma

AstraZeneca enlists SK Chemicals to produce diabetes combo drug Sidapvia - Fierce Pharma

AstraZeneca enlists SK Chemicals to produce diabetes combo drug Sidapvia Fierce Pharma

SK bioscience Unveils Equity Investment in Novavax - Contract Pharma

SK bioscience Unveils Equity Investment in Novavax Contract Pharma

Fierce Pharma Asiaβ€”Hengrui's FDA reprimands; Sanofi's India site expansion; Aslan's downfall - Fierce Pharma

Fierce Pharma Asiaβ€”Hengrui's FDA reprimands; Sanofi's India site expansion; Aslan's downfall Fierce Pharma

SK Capital Completes Acquisition of BFS from Catalent Pharma Solutions - Contract Pharma

SK Capital Completes Acquisition of BFS from Catalent Pharma Solutions Contract Pharma

FDA authorises SK Biopharmaceuticals' anti-epileptic drug Xcopri - FirstWord Pharma

FDA authorises SK Biopharmaceuticals' anti-epileptic drug Xcopri FirstWord Pharma

SK Bioscience helps keep Novavax afloat, buying 7% stake in vaccine maker for $85M - Fierce Pharma

SK Bioscience helps keep Novavax afloat, buying 7% stake in vaccine maker for $85M Fierce Pharma

Fierce Pharma Asiaβ€”Roche's $850M-plus deal with Regor; Legend's busy week; WuXi asset sales? - Fierce Pharma

Fierce Pharma Asiaβ€”Roche's $850M-plus deal with Regor; Legend's busy week; WuXi asset sales? Fierce Pharma

SK bioscience inks deal to support vaccine manufacturing in Thailand - Fierce Pharma

SK bioscience inks deal to support vaccine manufacturing in Thailand Fierce Pharma

SK pharmteco Doubles Viral Vector Production Capacity in Europe - Contract Pharma

SK pharmteco Doubles Viral Vector Production Capacity in Europe Contract Pharma

New Woodstock CEO Nick Buschur plots growth strategy for Illinois blow-fill-seal CDMO - Fierce Pharma

New Woodstock CEO Nick Buschur plots growth strategy for Illinois blow-fill-seal CDMO Fierce Pharma

Seqens Names Pascal Villemagne as CEO - Contract Pharma

Seqens Names Pascal Villemagne as CEO Contract Pharma

SK Life Science marks Purple Day for epilepsy awareness by highlighting patient support programs - Fierce Pharma

SK Life Science marks Purple Day for epilepsy awareness by highlighting patient support programs Fierce Pharma

South Korea's SK commits $350M to help build global cell and gene therapy CDMO - Fierce Pharma

South Korea's SK commits $350M to help build global cell and gene therapy CDMO Fierce Pharma

Fierce Pharma Asiaβ€”Big Pharma's China visit; AstraZeneca's parallel supply chains; WuXi's predicament - Fierce Pharma

Fierce Pharma Asiaβ€”Big Pharma's China visit; AstraZeneca's parallel supply chains; WuXi's predicament Fierce Pharma

SK Life Science plots 2020 launch for now-approved seizure drug Xcopri - Fierce Pharma

SK Life Science plots 2020 launch for now-approved seizure drug Xcopri Fierce Pharma

SK Biopharmaceuticals, Eurofarma Enter Cenobamate Licensing Pact in Latin America - Contract Pharma

SK Biopharmaceuticals, Eurofarma Enter Cenobamate Licensing Pact in Latin America Contract Pharma

SK Holdings Acquires Ampac Fine Chemicals - Contract Pharma

SK Holdings Acquires Ampac Fine Chemicals Contract Pharma

SK Biotek earmarks $35M for first expansion phase at Irish API plant - Fierce Pharma

SK Biotek earmarks $35M for first expansion phase at Irish API plant Fierce Pharma

Catalent inks deal to offload blow-fill-seal business to SK Capital - Fierce Pharma

Catalent inks deal to offload blow-fill-seal business to SK Capital Fierce Pharma

CEO Spotlight: Pierre Luzeau on Seqens U.S. R&D Lab Investment - Contract Pharma

CEO Spotlight: Pierre Luzeau on Seqens U.S. R&D Lab Investment Contract Pharma

Canadian CDMO OmniaBio debuts new cell and gene therapy manufacturing facility - Fierce Pharma

Canadian CDMO OmniaBio debuts new cell and gene therapy manufacturing facility Fierce Pharma

Fierce Pharma Asiaβ€”Pfizer's PD-1xVEGF bet; An Alzheimer's blood test approval; Samsung's biosim spinoff - Fierce Pharma

Fierce Pharma Asiaβ€”Pfizer's PD-1xVEGF bet; An Alzheimer's blood test approval; Samsung's biosim spinoff Fierce Pharma

AstraZeneca, Novavax partner SK Bioscience eyes $132M vaccine production boostβ€”and looks to add mRNA to the menu - Fierce Pharma

AstraZeneca, Novavax partner SK Bioscience eyes $132M vaccine production boostβ€”and looks to add mRNA to the menu Fierce Pharma

Social media mavens join SK Life Science's latest epilepsy awareness campaign to promote zero seizures goal - Fierce Pharma

Social media mavens join SK Life Science's latest epilepsy awareness campaign to promote zero seizures goal Fierce Pharma

After its breakout from Catalent, Woodstock Sterile Solutions emerges as a CDMO solo act - Fierce Pharma

After its breakout from Catalent, Woodstock Sterile Solutions emerges as a CDMO solo act Fierce Pharma

Cash-strapped bluebird bio to be sold for less than $30M upfront - FirstWord Pharma

Cash-strapped bluebird bio to be sold for less than $30M upfront FirstWord Pharma

SK advances Gates-backed COVID-19 antiviral spray toward clinic - Fierce Pharma

SK advances Gates-backed COVID-19 antiviral spray toward clinic Fierce Pharma

Bluebird bio warns of potential bankruptcy as buyout faces another delay - Fierce Pharma

Bluebird bio warns of potential bankruptcy as buyout faces another delay Fierce Pharma

SK bioscience, Vaxxas Partner on Needle-Free Patch Delivery of Typhoid Vax - Contract Pharma

SK bioscience, Vaxxas Partner on Needle-Free Patch Delivery of Typhoid Vax Contract Pharma

IDT Biologika Enters CMDO Partnership to Accelerate Global Growth - Contract Pharma

IDT Biologika Enters CMDO Partnership to Accelerate Global Growth Contract Pharma

Fierce Pharma Asiaβ€”Daiichi, Merck's FDA rejection; Wegovy's expansion; Takeda CEO's hunt for China deals - Fierce Pharma

Fierce Pharma Asiaβ€”Daiichi, Merck's FDA rejection; Wegovy's expansion; Takeda CEO's hunt for China deals Fierce Pharma

SK Life Science debuts Xcopri virtual effort for HCPs to empathize with seizure patients' experiences - Fierce Pharma

SK Life Science debuts Xcopri virtual effort for HCPs to empathize with seizure patients' experiences Fierce Pharma

2 ads for 2 audiences: SK Life targets docs and patients in seizure drug campaign - Fierce Pharma

2 ads for 2 audiences: SK Life targets docs and patients in seizure drug campaign Fierce Pharma

VIDEO: SK Biotek Opens First European Facility in Ireland - Contract Pharma

VIDEO: SK Biotek Opens First European Facility in Ireland Contract Pharma

Perrigo offloading its ingredient business to private equity investor for $110M - Fierce Pharma

Perrigo offloading its ingredient business to private equity investor for $110M Fierce Pharma

Sanofi inks 3 distribution pacts in India and Korea for CNS drugs and vaccines - Fierce Pharma

Sanofi inks 3 distribution pacts in India and Korea for CNS drugs and vaccines Fierce Pharma

Cambrex closes on $425M deal for dosage-form CDMO Halo Pharma - Fierce Pharma

Cambrex closes on $425M deal for dosage-form CDMO Halo Pharma Fierce Pharma

With $71M investment, French CDMO Yposkesi set to double capacity and become a viral vector force - Fierce Pharma

With $71M investment, French CDMO Yposkesi set to double capacity and become a viral vector force Fierce Pharma

South Korean company buys CDMO AMPAC - Fierce Pharma

South Korean company buys CDMO AMPAC Fierce Pharma

South Korean CDMO consolidates, plants flag in California - Fierce Pharma

South Korean CDMO consolidates, plants flag in California Fierce Pharma

Merger roundup: bluebird purchase terms adjusted, Alumis agrees to Acelyrin deal - FirstWord Pharma

Merger roundup: bluebird purchase terms adjusted, Alumis agrees to Acelyrin deal FirstWord Pharma

Former Sanofi and BMS plants in EU reclaimed by Asian drugmakers - Fierce Pharma

Former Sanofi and BMS plants in EU reclaimed by Asian drugmakers Fierce Pharma

Bristol-Myers selling Ireland plant to South Korean company with large aspirations - Fierce Pharma

Bristol-Myers selling Ireland plant to South Korean company with large aspirations Fierce Pharma

BioDuro boosts peptide production in China with new manufacturing plant - Fierce Pharma

BioDuro boosts peptide production in China with new manufacturing plant Fierce Pharma

Noramco and AFC strike deal for controlled substance APIs - Fierce Pharma

Noramco and AFC strike deal for controlled substance APIs Fierce Pharma

As Shingrix rivalry looms in the U.S., Merck's Zostavax yields share in Korea to SK’s Skyzoster - Fierce Pharma

As Shingrix rivalry looms in the U.S., Merck's Zostavax yields share in Korea to SK’s Skyzoster Fierce Pharma

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant